US Trade War Update: 100% Pharma Tariffs & Lingering Economic Impact
📈 US Trade War: 100% Pharma Tariffs & Economic Fallout
A year after Trump's "Liberation Day" tariffs, the trade war continues to reshape how American companies model economic and policy risk.
Latest Developments:
• US imposed 100% tariffs on foreign pharmaceuticals in early April
• Supreme Court vacated IEEPA tariffs on Feb 20, 2026
• IMF completed Article IV Consultation — US grew 2% in 2025 despite disruptions
• Global fuel volatility from Iran war adding to trade uncertainty
Economic Impact:
• Retail and auto industries retooling supply chains
• Low-hire, low-fire labor market persists
• Interest rate decisions remain data-dependent
• Stock market resilient but analysts warn of bubble risks
Yale Budget Lab is tracking real-time effects: tariff rates have fallen since the court ruling but the structural impact on global trade patterns is lasting.
As one analyst put it: "Tariff may be the most beautiful word in the dictionary" for Trump, but American consumers and businesses are still paying the price.
0
0
0
No comments yet